Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Stefan Freudenberg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine Technology|November 11, 2018
In Patients We Trust: Reliability of Self-Reported Weight and Height in Nuclear Medicine PatientsKatrin Sabine Blum, Nadine Büsch, Thomas Beyer, et al.
Clinical Nuclear Medicine|February 8, 2012
Effects of rosiglitazone on radioiodine negative and progressive differentiated thyroid carcinoma as assessed by ¹²⁴I PET/CT imagingSandra Julia Rosenbaum-Krumme, Lutz Stefan Freudenberg, Walter Jentzen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 28, 2010
Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisonsLutz Stefan Freudenberg, Walter Jentzen, Thorsten Petrich, et al.
Nuklearmedizin. Nuclear Medicine|April 3, 2020
Bernd Joachim Krause, Peter Bartenstein, Lutz Stefan Freudenberg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine Technology|November 11, 2018
In Patients We Trust: Reliability of Self-Reported Weight and Height in Nuclear Medicine PatientsKatrin Sabine Blum, Nadine Büsch, Thomas Beyer, et al.
Clinical Nuclear Medicine|February 8, 2012
Effects of rosiglitazone on radioiodine negative and progressive differentiated thyroid carcinoma as assessed by ¹²⁴I PET/CT imagingSandra Julia Rosenbaum-Krumme, Lutz Stefan Freudenberg, Walter Jentzen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 28, 2010
Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisonsLutz Stefan Freudenberg, Walter Jentzen, Thorsten Petrich, et al.
Nuklearmedizin. Nuclear Medicine|April 3, 2020
Bernd Joachim Krause, Peter Bartenstein, Lutz Stefan Freudenberg, et al.
Pageof 1